deltatrials
Unknown NA INTERVENTIONAL 1-arm NCT00912080

Utilization of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer (SA02)

Utilisation of Genomic Signature as Decision-making for Adjuvant Treatment of Breast Cancer: A Prospective Cohort Study.

Sponsor: Institut Paoli-Calmettes

Conditions Breast Cancer
Interventions genomic signature
Updated 5 times since 2017 Last updated: Mar 19, 2013 Started: Apr 30, 2007 Primary completion: May 31, 2015 Completion: May 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00912080, this NA trial focuses on Breast Cancer and remains ongoing. Sponsored by Institut Paoli-Calmettes, it has been updated 5 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jun 2018 — Jan 2021 [monthly]

    Unknown Status NA

  5. Jan 2017 — Jun 2018 [monthly]

    Unknown Status NA

    First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Institut Paoli-Calmettes
Data source: Institut Paoli-Calmettes

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations